It is important to note that some patients report that injection site symptoms diminish over time with continued use
in fact, allowing the body to acclimate can prevent treatment interruptions , so patients actually receive more cumulative exposure to the medication over time
Preliminary animal and small human studies suggest allulose may modestly stimulate GLP-1 secretion and reduce postprandial glucose
Your gut produces this hormone after eating
While those results are encouraging, direct comparisons between Retatrutide and tirzepatide should be interpreted carefully because the medications have been studied in different clinical trials with different patient populations, treatment durations, and study designs
Visual impairment and visual worsening No differences in visual impairment between groups were seen (Supplementary Table 3), with visual impairment being associated with visual impairment at baseline (M3: \(\beta\)=0.79, 95% CI 0.54, 1.03